Skip to Content

Join the 'Nausea / Vomiting - Chemotherapy Induced' group to help and get support from people like you.

Nausea / Vomiting - Chemotherapy Induced News

FDA Approves Cinvanti (aprepitant) Injectable Emulsion for the Prevention of Acute and Delayed Chemotherapy-Induced Nausea and Vomiting (CINV)

Posted 4 days ago by Drugs.com

SAN DIEGO--(BUSINESS WIRE)--Nov. 9, 2017-- Heron Therapeutics, Inc. (Nasdaq: HRTX) (the Company or Heron), a commercial-stage biotechnology company focused on developing novel, best-in-class treatments to address some of the most important unmet patient needs, today announced that the U.S. Food and Drug Administration (FDA) has approved Cinvanti (aprepitant) injectable emulsion, for intravenous infusion. Cinvanti is a substance P/neurokinin-1 (NK1) receptor antagonist, indicated in adults, in combination with other antiemetic agents, for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin and nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC). Cinvanti is the first and only polysorbate 80-free, ... Read more

Related support groups: Chemotherapy, Nausea/Vomiting - Chemotherapy Induced, Emend, Aprepitant, Cinvanti, Emend for Injection

Tesaro Announces U.S. FDA Approval of Varubi IV for Delayed Nausea and Vomiting Associated With Cancer Chemotherapy

Posted 20 days ago by Drugs.com

WALTHAM, Mass., Oct. 25, 2017 (GLOBE NEWSWIRE) – Tesaro, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Varubi (rolapitant) IV in combination with other antiemetic agents in adults for the prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy. Delayed nausea and vomiting can occur anytime between 25 and 120 hours following chemotherapy, and is often extremely debilitating. About Varubi Varubi is a highly selective and competitive antagonist of human substance P/neurokinin 1 (NK-1) receptors, which play an important role in the delayed phase of chemotherapy-induced nausea and vomiting (CINV). With a long plasma half-life of approximately seven days, a single ... Read more

Related support groups: Chemotherapy, Nausea/Vomiting - Chemotherapy Induced, Varubi, Rolapitant

Medical Marijuana Won't Help Most Sick Kids

Posted 23 Oct 2017 by Drugs.com

MONDAY, Oct. 23, 2017 – Medical marijuana appears to hold only limited promise for sick children and teenagers, a new review suggests. It can help kids fighting cancer with chemotherapy-related nausea and vomiting, and it can control seizures somewhat in children with epilepsy, said study author Dr. Shane Shucheng Wong. He is a psychiatrist with Massachusetts General Hospital, in Boston. But there's not enough evidence to say that medical marijuana can help kids with any other medical conditions, such as neuropathic pain, post-traumatic stress disorder (PTSD) or Tourette's syndrome, Wong added. Medical marijuana is now legal in 29 states and the District of Columbia, making it potentially available as a medication for kids. "Children and adolescents can legally access medical cannabis if they have certification from a doctor and from their legal guardian," Wong said. "As a result, ... Read more

Related support groups: Seizures, Seizure Prevention, Marinol, Cannabis, Tourette's Syndrome, Seizure Prophylaxis, Nausea/Vomiting - Chemotherapy Induced, Nabilone, Dronabinol, Cesamet, Syndros

9 of 10 Docs Unprepared to Prescribe Marijuana

Posted 19 Sep 2017 by Drugs.com

TUESDAY, Sept. 19, 2017 – Although it's becoming more commonplace, medical marijuana is rarely discussed in U.S. medical schools, a new study shows. "Medical education needs to catch up to marijuana legislation," said senior author Dr. Laura Jean Bierut, a professor of psychiatry at Washington University School of Medicine in St. Louis. "Physicians in training need to know the benefits and drawbacks associated with medical marijuana so they know when or if, and to whom, to prescribe the drug," she explained in a school news release. Marijuana is now legal – at least for medical purposes – in more than half the states in the country, the researchers said. Curriculum deans at 101 medical schools completed surveys about marijuana education. Just over two-thirds said their graduates weren't prepared to prescribe medical marijuana. One-quarter said their graduates weren't even able to ... Read more

Related support groups: Pain, Nausea/Vomiting, Cannabis, Nausea/Vomiting - Chemotherapy Induced, Nausea/Vomiting - Radiation Induced

Cancer Treatment Can Affect Your Food Preferences

Posted 19 Sep 2017 by Drugs.com

TUESDAY, Sept. 19, 2017 – Cancer therapies often change patients' sense of taste, which may affect what they like to eat, according to a nutrition expert. "Increased taste sensitivities are more common than a muting of taste," said Catherine Carpenter, professor of clinical nutrition at UCLA's David Geffen School of Medicine. "Usually, the type of taste sensitivity encountered is one of a metallic nature." Changes in tastes often influence a person's food preferences, but treatment may affect individuals differently, Carpenter noted in a university news release. "If anything, patients tend to prefer bland foods rather than spicy foods," she said. "It's important to remember that preferences may vary depending on the cancer and type of treatment. You cannot lump all cancer patients into one dietary regimen." After treatments, such as chemo or radiation therapy, a nutritionist can help ... Read more

Related support groups: Cancer, Methotrexate, Breast Cancer, Xerostomia, Oral and Dental Conditions, Fluorouracil, Colorectal Cancer, Xeloda, Hydroxyurea, Nausea/Vomiting - Chemotherapy Induced, Mercaptopurine, Hydrea, Capecitabine, Gemzar, Dacogen, Gemcitabine, Cytarabine, Cladribine, Decitabine, Fludara

Germs, Mold Found in Some Medical Pot

Posted 15 Feb 2017 by Drugs.com

WEDNESDAY, Feb. 15, 2017 – Medical marijuana carries infectious bacteria and fungi that can pose a life-threatening risk to cancer patients who use pot to help with side effects of chemotherapy, a new study suggests. The study was initially prompted by the death of a man using medical marijuana to combat the side effects of cancer treatment. His death was believed to be caused by a fungus from his marijuana, his doctor said. Study researchers tested 20 different samples of dried marijuana obtained from Northern California dispensaries and found several potentially dangerous pathogens in the samples. The germs found by the researchers wouldn't harm an average pot user, but could be potentially fatal to people whose immune systems have been suppressed, said lead researcher Dr. George Thompson III. "We found basically everything that, if you're really immunosuppressed, you don't want," ... Read more

Related support groups: Pain, Infections, Nausea/Vomiting, Cancer, Chronic Pain, Vomiting, Bacterial Infection, Fungal Infections, Cannabis, Nausea/Vomiting - Chemotherapy Induced, Nausea/Vomiting - Postoperative, Nausea/Vomiting - Radiation Induced, Mucormycosis, Invasive

Is Chemo Overused in Younger Colon Cancer Patients?

Posted 25 Jan 2017 by Drugs.com

WEDNESDAY, Jan. 25, 2017 – Young and middle-aged colon cancer patients may be getting chemotherapy more often than is warranted, a new study suggests. "Most of the young patients received postoperative systemic chemotherapy, including multi-[drug] regimens, which are currently not recommended for most patients with early stage colon cancer," the study authors wrote. The research team was led by Dr. Kangmin Zhu from the Walter Reed National Military Medical Center in Bethesda, Md. Overall, the findings "suggest overtreatment of young and middle-aged adults with colon cancer," Zhu and colleagues concluded. One colon cancer expert who reviewed the study said it addresses an often difficult question. "There is a rising trend of younger patients being diagnosed with colon cancer," said Dr. Anna Levy. She's an oncologist at Northwell Health Cancer Institute in Lake Success, N.Y. "The premise ... Read more

Related support groups: Cancer, Colonoscopy, Colorectal Cancer, Nausea/Vomiting - Chemotherapy Induced, Familial Adenomatous Polyposis

Vomiting Disorder on Rise in Weed-Friendly Colorado

Posted 6 Jan 2017 by Drugs.com

THURSDAY, Jan. 5, 2017 – Long-term heavy marijuana use can cause chronic vomiting and abdominal pain in some people, new research suggests. And the syndrome could become more frequent and pervasive as more states legalize use of the drug, according to health experts. Cases of the disorder, which is called cannabinoid hyperemesis syndrome (CHS), doubled in Colorado as access to legal marijuana became widespread, said Dr. Kennon Heard. He is chief of medical toxicology for the University of Colorado Anschutz Medical Campus. "All of the emergency departments in the state now are seeing this on a daily to weekly basis," Heard said. "There are a lot of patients ending up in the emergency room with this, and presumably there are even more who don't come to the emergency room, who just ride it out at home." Patients who develop the syndrome typically smoke marijuana on a daily basis, and have ... Read more

Related support groups: Nausea/Vomiting, Vomiting, Gastrointestinal Disorders, Cannabis, Motion Sickness, Nausea/Vomiting - Chemotherapy Induced, Nausea/Vomiting - Postoperative, Nausea/Vomiting of Pregnancy

Heron Therapeutics Announces FDA Approval of Sustol (granisetron) Extended-Release Injection for the Prevention of Chemotherapy-Induced Nausea and Vomiting

Posted 10 Aug 2016 by Drugs.com

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Aug. 10, 2016-- Heron Therapeutics, Inc. (NASDAQ:HRTX), today announced that the U.S. Food and Drug Administration (FDA) has approved Sustol (granisetron) extended-release injection. Sustol is a serotonin-3 (5-HT3) receptor antagonist indicated in combination with other antiemetics in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (MEC) or anthracycline and cyclophosphamide (AC) combination chemotherapy regimens. Sustol is an extended-release, injectable 5-HT3 receptor antagonist that utilizes Heron’s Biochronomer® polymer-based drug delivery technology to maintain therapeutic levels of granisetron for ≥5 days, covering both the acute and delayed phases of chemotherapy-induced nausea and vomiting (CINV). “Despite advances in the management of CINV, u ... Read more

Related support groups: Nausea/Vomiting - Chemotherapy Induced, Sustol, Granisetron

Insys Therapeutics Announces FDA Approval of Syndros (dronabinol) Oral Solution

Posted 5 Jul 2016 by Drugs.com

PHOENIX, July 05, 2016 (GLOBE NEWSWIRE) – Insys Therapeutics, Inc. (“Insys” or “the Company”) (NASDAQ:INSY) today announced that the U.S. Food and Drug Administration (FDA) has approved Insys’ dronabinol oral solution, Syndros, an orally administered liquid formulation of the pharmaceutical cannabinoid dronabinol, a pharmaceutical version of tetrahydrocannabinol ("THC"). Syndros is approved for use in treating anorexia associated with weight loss in patients with AIDS, and nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments. Syndros is currently awaiting scheduling by the U.S. Drug Enforcement Administration. "We are very pleased to announce FDA approval of Syndros. We believe that Syndros will be an important new treatment option for patients suffering from the devastating effects of chemothe ... Read more

Related support groups: Chemotherapy, Anorexia, Nausea/Vomiting - Chemotherapy Induced, AIDS Related Wasting, Dronabinol, Syndros

Cancer's Heavy Financial Burden

Posted 8 Jun 2016 by Drugs.com

WEDNESDAY, June 8, 2016 – Many cancer patients can't afford to see their doctor or take the medications they've been prescribed, a new study finds. And the problem will likely only get worse as the cost of cancer treatments continues to rise, the study authors said. "You can prescribe the best drug in the world, but if patients can't afford it and they can't get it, then it won't be effective," said study author Dr. Greg Knight. He is chief fellow with the University of North Carolina School of Medicine's division of hematology and oncology. "We saw a significant portion of patients in our study who were stretching their prescriptions or not coming to the doctor's office," Knight said in a university news release. The researchers reviewed survey results from nearly 2,000 patients at the N.C. Cancer Hospital in Chapel Hill, N.C. The participants were all 18 and older, and had been ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Gleevec, Colorectal Cancer, Brain Tumor, Votrient, Skin Cancer, Tarceva, Ovarian Cancer, Melanoma, Avastin, Tasigna, Endometrial Cancer, Sprycel, Sutent, Herceptin, Afinitor, Bladder Cancer

Researchers Find 8 Immune Genes in Aggressive Brain Cancer

Posted 25 May 2016 by Drugs.com

WEDNESDAY, May 25, 2016 – Researchers have identified immune genes that may affect how long people live after diagnosis with a common type of brain cancer. If confirmed in other studies, the researchers say their findings could lead to improved treatment in the future. The type of brain cancer in the study is glioblastoma multiforme, a fast-growing tumor. People with this type of cancer survive an average of less than two years, even after treatment with surgery, radiation and chemotherapy, the study authors said. "We've had luck with other types of cancer in removing the brakes on the immune system to allow it to fight the tumors, but this has not been the case with glioblastoma," said study author Dr. Anhua Wu, of First Hospital of China Medical University in Shenyang, China. "If our discovery of these genes is validated in other studies, we could use this 'gene signature' to ... Read more

Related support groups: Surgery, Brain Tumor, Nausea/Vomiting - Chemotherapy Induced, Head & Neck Surgery, Glioblastoma Multiforme, Diagnosis and Investigation, Malignant Glioma, Head Imaging

Additional Treatments Offer Little Benefit for Pancreatic Cancer: Study

Posted 3 May 2016 by Drugs.com

TUESDAY, May 3, 2016 – Additional treatments for locally advanced pancreatic cancer don't appear to boost survival, a new French study reports. Researchers looked at the effects of adding a second drug – erlotinib (Tarceva) – to the initial round of chemotherapy. They also tested whether adding radiation to a second round of chemotherapy (chemoradiotherapy) would offer any survival benefit. Unfortunately, the addition of the second drug didn't help people live longer, and those on chemoradiotherapy didn't fare any better. "Chemoradiotherapy was not superior to chemotherapy," said the study's senior author, Dr. Pascal Hammel. Hammel is from the department of gastroenterology-pancreatology at Beaujon Hospital, in Clichy, France. The study was funded by the pharmaceutical company Roche, the maker of Tarceva, and the French National Institute of Cancer. More than 53,000 Americans are ... Read more

Related support groups: Tarceva, Pancreatic Cancer, Nausea/Vomiting - Chemotherapy Induced, Erlotinib, History - Radiation Therapy

Could Talk Therapy Ease Chemo-Related Memory Issues?

Posted 2 May 2016 by Drugs.com

MONDAY, May 2, 2016 – A type of psychotherapy might help cancer survivors deal with the long-term thinking problems some experience after chemotherapy, researchers say. It's estimated that about half of those who undergo chemotherapy for cancer develop what's often called "chemo brain." For instance, they may have trouble following conversations or remembering the steps in a project, according to background notes with the new study. Although usually mild, these changes can affect quality of life, job performance and relationships, said the researchers from the Eastern Maine Medical Center and Lafayette Family Cancer Center in Bangor, Maine. The researchers developed a cognitive-behavioral therapy (CBT) program called Memory and Attention Adaptation Training to help cancer survivors prevent or manage these memory problems. Their study involved 47 breast cancer survivors who underwent ... Read more

Related support groups: Cancer, Methotrexate, Breast Cancer, Prostate Cancer, Fluorouracil, Lung Cancer, Gleevec, Renal Cell Carcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Skin Cancer, Ovarian Cancer, Melanoma, Xeloda, Tasigna, Endometrial Cancer, Pancreatic Cancer, Sprycel

Many Breast Cancer Patients May Not Need Chemo: Study

Posted 18 Apr 2016 by Drugs.com

MONDAY, April 18, 2016 – Many breast cancer patients receive chemotherapy they don't need, according to the results of a long-awaited clinical trial. A genetic test called MammaPrint determined that nearly half the women slated for chemotherapy based on standard clinical assessments didn't really need to undergo the challenging treatment. Researchers planned to announce the findings Monday at the American Association for Cancer Research (AACR) meeting in New Orleans. After surgery to remove their tumors, breast cancer patients with a MammaPrint score recommending against chemotherapy had a 95 percent survival rate, said co-researcher Laura van 't Veer, the test's inventor. "That's very high, and we showed that it doesn't differ between those who are treated and those who are not treated by chemotherapy," said van 't Veer, leader of the breast oncology program at the University of ... Read more

Related support groups: Breast Cancer, Nausea/Vomiting - Chemotherapy Induced, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Diagnosis and Investigation

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Nausea / Vomiting

Related Drug Support Groups

gabapentin, Ativan, lorazepam, Zofran, olanzapine, dexamethasone, Reglan, ondansetron, Marinol, view more... cannabis, Decadron, metoclopramide, nabilone, dronabinol, Cesamet, Zofran ODT, Kytril, Emend, Varubi, Lorazepam Intensol, Adrenocot, Maxolon, Syndros, Dexone, Sustol, Sancuso, Adrenocot LA, Emend for Injection, Baycadron, Zuplenz, Dexamethasone Intensol, aprepitant, Dalalone, Dalalone DP, Dalalone LA, Decaject, Decaject LA, Zema Pak, Akynzeo, Zonacort, LoCort, Granisol, De-Sone LA, Dexpak Taperpak, Decadron-LA, dolasetron, granisetron, palonosetron, fosaprepitant, netupitant / palonosetron, rolapitant, Anzemet, Aloxi, Hexadrol, Solurex LA, Medidex LA, Dexacen-4, Solurex, Dexacort-LA, Dexasone, Dexasone LA, Dexone LA, Primethasone, Dexacorten, Medidex, Cinvanti